Stanley Frencher to Prostate-Specific Antigen
This is a "connection" page, showing publications Stanley Frencher has written about Prostate-Specific Antigen.
Connection Strength
0.465
-
Garraway IP, Carlsson SV, Nyame YA, Vassy JL, Chilov M, Fleming M, Frencher SK, George DJ, Kibel AS, King SA, Kittles R, Mahal BA, Pettaway CA, Rebbeck T, Rose B, Vince R, Winn RA, Yamoah K, Oh WK. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. NEJM Evid. 2024 May; 3(5):EVIDoa2300289.
Score: 0.223
-
Wallner LP, Frencher SK, Hsu JW, Chao CR, Nichol MB, Loo RK, Jacobsen SJ. Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population. BJU Int. 2013 Jun; 111(8):1245-52.
Score: 0.102
-
Wallner L, Frencher S, Hsu JW, Loo R, Huang J, Nichol M, Jacobsen S. Prostate cancer screening trends in a large, integrated health care system. Perm J. 2012; 16(3):4-9.
Score: 0.095
-
Nichol MB, Wu J, Huang J, Denham D, Frencher SK, Jacobsen SJ. Cost-effectiveness of Prostate Health Index for prostate cancer detection. BJU Int. 2012 Aug; 110(3):353-62.
Score: 0.023
-
Nichol MB, Wu J, An JJ, Huang J, Denham D, Frencher S, Jacobsen SJ. Budget impact analysis of a new prostate cancer risk index for prostate cancer detection. Prostate Cancer Prostatic Dis. 2011 Sep; 14(3):253-61.
Score: 0.023